Writing in Technology Networks Genomics Research, Jason Potter, claims that the stage is set for 2023 to be a milestone year for genetic medicine. He explains how the next ten years will likely bring genome editing to market for an array of rare, debilitating conditions.
The next ten years of genome editing in the clinic
Image by Matthew Daniels via the Wellcome Collection. Depicts human cells, showing the stages of cell division.
« Gene expression precisely controlled by artificial intelligence and CRISPR
